Scientific Leadership Committee

On this page:

Terrence Forrester.

Terrence Forrester, PhD, DM

Professor, University of the West Indies, Mona Campus

Terrence Forrester holds fellowships in the Royal College of Physicians of both London and Edinburgh and is a professor of experimental medicine at the University of the West Indies Mona Campus.

His research focuses on risks and impacts of obesity, metabolic programming of early life and the constraints of fetal growth, and understanding the economic implications of chronic diseases and their intervention. He spearheaded the formation of the Tropical Medical Research Institute, which unified four research units—the Tropical Metabolic Research Unit, the Sickle Cell Research Unit, the Epidemiology Research Unit at Mona, Jamaica, and the Chronic Disease Research Unit in Barbados—across three campuses of the University of the West Indies.

James Hakim.

James Hakim, MBChB, MRCP, DSc

Professor, University of Zimbabwe

James Hakim is a professor of medicine at the University of Zimbabwe in the College of Health Sciences, and is a cardiologist with more than 20 years of experience conducting clinical trials. He is the leader of the University of Zimbabwe Parirenyatwa Clinical Research Site and is an active member of the NIH AIDS Clinical Trials Group network. Professor Hakim has served as a member of the Scientific Agenda Steering Committee, Antiretroviral Committee and HPTN Executive Committee. 

Dr. Lindo.

John F. Lindo, PhD

Deputy Dean for Research, University of the West Indies, Mona Campus

John Lindo also is a consultant parasitologist to the University Hospital of West Indies. Professor Lindo is co-chair of the SUNY-University of the West Indies Faculty Task Force for Health Research Development. His research has focused on the epidemiology of soil-transmitted helminths and emerging infectious diseases. This includes the epidemiology of strongyloides stercoralis infections and toxocariasis, the emergence of malaria and angiostrongylus cantonensis infections in Jamaica, epidemiology of free-living amoebae in Jamaica and opportunistic parasitic infections in persons living with HIV/AIDS.  

charles chiedza maponga.

Charles Chiedza Maponga, PharmD, MPHE

Senior Lecturer and Director, School of Pharmacy, University of Zimbabwe College of Health Sciences

Charles Chiedza Maponga also holds a visiting faculty position with the UB School of Pharmacy and Pharmaceutical Sciences. He travels frequently between UB and the University of Zimbabwe while coordinating the activities of an international collaborative program, the International Pharmacotherapy Education and Research Initiative. Professor Maponga is the University of Zimbabwe's principal investigator for the NIH Fogarty International Center HIV Research Training program. He works to implement a postgraduate and postdoctoral training initiative between the two universities with an emphasis on HIV clinical pharmacology.

charles chiedza maponga.

Craig Hendrix, MD

Wellcome Professor and Director, Division of Clinical Pharmacology, Johns Hopkins University School of Medicine

Craig Hendrix is currently the Wellcome Professor and Director, Division of Clinical Pharmacology, Johns Hopkins University School of Medicine. He trained in infectious diseases and clinical pharmacology at Hopkins before a career in the US Air Force and at Johns Hopkins.

Dr. Hendrix’s primary research focus is clinical pharmacology of HIV pre-exposure prophylaxis. Among other research projects, he’s involved as Principal Investigator or Project Leader in a variety of early phase PrEP program project grants funded through the DAIDS Integrated Clinical/Preclinical HIV Topical Microbicide Program. He also serves as director of the pharmacology group for the MTN and HPTN.

Tim Murphy.

Timothy Murphy, MD

SUNY Distinguished Professor

Senior Associate Dean for Clinical and Translational Research, University at Buffalo

Timothy Murphy is a SUNY distinguished professor and senior associate dean for Clinical and Translational Research in UB's Jacobs School of Medicine and Biomedical Sciences. He oversees strategies to transform UB’s research programs into new or improved treatments for patients as well as assisting faculty and trainees at all levels with their research activities. He directs the school's Clinical and Translational Research Center, located on the Buffalo Niagara Medical Campus that includes a nine-bed clinical research center with support services for clinical research. He focuses on infectious diseases.

Paras Prasad.

Paras N. Prasad, PhD

SUNY Distinguished Professor of Chemistry, Physics, Medicine and Electrical Engineering, University at Buffalo

Paras Prasad also holds the Samuel P. Capen Chair at UB and is the executive director of the multidisciplinary Institute for Lasers, Photonics and Biophotonics. He has published more than 700 scientific papers, co-edited six books and co-authored a monograph (with D.J. Williams) "Introduction to Nonlinear Optical Effects in Molecules and Polymers." Professor Prasad published "Introduction to Biophotonics," the first monograph in this field, which authoritatively defines the field, details its scope and identifies emerging opportunities. He also has published the monograph, "Nanophotonics" and "Introduction to Nanomedicine and Nanobioengineering."

stanley schwartz.

Stanley Schwartz, MD, PhD

UB Distinguished Professor of Medicine, Pediatrics, and Microbiology & Immunology, University at Buffalo

Division Chief, Allergy-Immunology-Rheumatology

Chief of Medicine, Kaleida Health

Stanley Schwartz is working to develop unique therapies for treatment of metastatic prostate cancer and chronic viral infections involving the brain. The processes include  nanotechnology, as well as allergy and immunology, proteins, metalloenzymes and RNA.

Andrew Talal.

Andrew Talal, MD, MPH

Professor of Medicine, Gastroenterology, Hepatology and Nutrition, University at Buffalo

Andrew Talal conducts clinical and translational research in viral hepatitis. He studies viral decay and the concentrations of drugs in the liver. He directs the Center for Clinical Care and Research in Liver Disease at UB’s Clinical and Translational Research Center. His lab has received multi-year funding for its research programs. It has developed techniques for animal and human liver sampling that enable sorting of liver cells in order to understand drug distribution in the liver during treatment. 

James Mohler.

James Mohler, MD

Associate Director for Translational Research, Chief, Inter-Institutional Academics, and Professor of Oncology, at Roswell Park Comprehensive Cancer Center (Roswell Park)

James Mohler earned his medical degree from the Medical College of Georgia and completed residency training in Surgery and Urology at the University of Kentucky Medical Center and a research fellowship in Urologic Oncology at The Johns Hopkins University School of Medicine.  Dr. Mohler is licensed by New York and North Carolina, a Diplomate of the National Board of Medical Examiners and the American Board of Urology, and a Fellow of the American College of Surgeons. He was Chair of the Roswell Park Department of Urology for 14 years.  Dr. Mohler is Chair of the National Comprehensive Cancer Network (NCCN) Guidelines Panel for Prostate Cancer and Past-President of the Society for Basic Urologic Research (SBUR). He has received the Producers Award and the Rodger J. Winn Award from NCCN and a career achievement award from SBUR.

Andrew Talal.

Peter A Anton, MD

Director of the UCLA CFAR Mucosal Immunology Research Laboratory (MICL), Director of the UCLA Center for HIV Prevention Research (CPR)

Dr. Anton graduated magna cum laude from Harvard University in 1977 and received his MD from Case Western Reserve University in 1983. He did fellowship work at the Cholera Hospital, ICDDR, in Bangladesh in 1983 and a year fellowship in pathology in 1981 in Cleveland’s Institute of Pathology. He performed his internship and residency in internal medicine at Bringham and Women’s Hospital in Boston Massachusetts. Dr. Anton began in his work at UCLA in 1986 with a gastroenterology fellowship and has been on faculty since 1989.

Dr. Anton’s research focuses on the degree of mucosal inflammation and altered co-receptor expression associated with HIV infection and associated therapeutic interventions, the potential use of the mucosa as a route of HIV immunization with various HIV vaccine candidates as well as microbicides for HIV mucosal prevention, investigating the interaction of HSV and HIV in mucosal pathogenesis and efforts to clarify the role of compartments in HIV pathogenesis.

Sustainable Development Leadership Committee

On this page:

Lauren Barredo

Head of Partnerships, Sustainable Development Solutions Network

Lauren Barredo is Head of Partnerships for the SDSN, where she manages relationships with institutions, companies, and individuals, finding new ways to collaborate on SDG implementation. In addition, she manages three Thematic Networks (Health, Agriculture, and Extractive and Land Resources) as well as three Regional Networks (Amazon, Australia Pacific, and Caribbean).

Robin DiFrancesco

Scientific Manager, CIGBS, University at Buffalo

Robin DiFrancesco, MT ASCP, MBA has over 30 years of experience in pharmacology research (20+ in HIV research) and has a variety of knowledge, practical and theoretical, to offer our global students. She is appointed at the UB School of Pharmacy and Pharmaceutical Sciences as a research assistant professor and as a voluntary adjunct faculty member for the UB Department of Biotechnology and Clinical Sciences within the Jacobs School of Medicine and Biomedical Sciences. She holds an ACSP certification as a medical technologist and a NYS license as a clinical laboratory technologist.

Andrew Talal.

Karl Donn, PhD

Vice President of the Drug Development Parion Sciences, Vice President of Pulmonary Development

Karl Donn is currently Vice President, Respiratory R&D. He led the drug discovery program that resulted in the selection of P-1037 as a potent and durable epithelial sodium channel blocker for inhaled delivery to patients with cystic fibrosis, COPD and other respiratory diseases. He continues to lead the development of P-1037 through clinical trials. He also leads tPAD clinical development and led a variety of discovery and early development programs for at Parion. Karl has over 30 years of drug development experience in both small and large pharmaceutical companies. 

Andrew Talal.

Ative Ennis

Head of Innovation and Enterprise Solutions, Digicel

Former director of Innovation and Enterprise Solutions for Digicel Business, Ative Ennis, will lead product development and will drive an improved customer experience in his new role as commercial director (B2B) for Digicel Business. Morin stated, “Ative will add his significant experience in business technology modernisation to help companies leverage their data assets for profitability. Delroy has been instrumental to developing a truly unbeatable fibre-to-the-home service for our customers to experience the speed and benefits of a new phase of Internet connectivity. Together, they will strengthen our leadership team as we work to deepen our relationship with our customers.”

Andrew Talal.

Matt Enstice

Chief Executive Officer, Buffalo Niagara Medical Campus

Current President and CEO of the Buffalo Niagara Medical Campus, Inc, Matt Enstice leads this pioneering organization that has become a powerful engine of revitalization in Buffalo. He is focused on the intersection of energy, entrepreneurship and technology, and how it will drive the new economy in Buffalo and beyond.

Andrew Talal.

Garthfield Gibson

Comptroller, Spectrum Radiology Associates

Garthfield Gibson was named a trustee for the Nichols School. He serves as the comptroller for Spectrum Radiology Associates. Members of the board of trustees are principally charged with the strategic, long-term protection and strengthening of the financial, physical and programmatic assets of the school, while manifesting the mission of the school. Board members have a three-year term, and serve on at least one standing committee of the board.

Andrew Talal.

John Hatcher

Vice President of Business Development, Accessium Group

John Mead Hatcher, President of JMH Advisement, LLC, has over 35 years of experience in business development and brings his vast network of contacts within the specific fields of finance, research, politics and business associations together to enable startups, early-stage, as well as, full-fledged operating companies for the purpose of achieving their business goals and objectives.

Andrew Talal.

Gabriella Heffesse

Chief Operating Officer, ACG Analytics

Gabriella Heffesse joined ACG Analytics in 2014 and focuses on client relations, business development, and analyzing policy effects on capital markets. Since joining ACGA she has led trips for clients to meet with governments and officials in several countries including Greece, Argentina, Germany, and the United States.

Andrew Talal.

John Lindo, PhD

Deputy Dean for Research, University of the West Indies, Mona Campus

Professor Lindo John is a Full Professor of Parasite Epidemiology, Faculty of Medical Sciences at The University of the West Indies (UWI), Mona campus and Deputy Dean (Research). His extensive experience with Vector borne diseases comes in part from a sabbatical year spent with the Neglected Tropical Diseases Unit at the Pan American Health Organization (PAHO) in Washington DC. During his time at PAHO he worked on the elimination of schistosomiasis in the Americas which included a visit to inspect transmission sites in Suriname and facilitating a workshop in Grenada with experts from academia, WHO, CARPHA and CDC.

Andrew Talal.

Charles Chiedza Maponga, PharmD, MPHE

Senior Lecturer and Director, School of Pharmacy, University of Zimbabwe College of Health Sciences

Charles Chiedza Maponga also holds a visiting faculty position with the UB School of Pharmacy and Pharmaceutical Sciences. He travels frequently between UB and the University of Zimbabwe while coordinating the activities of an international collaborative program, the International Pharmacotherapy Education and Research Initiative. Professor Maponga is the University of Zimbabwe's principal investigator for the NIH Fogarty International Center HIV Research Training program. He works to implement a postgraduate and postdoctoral training initiative between the two universities with an emphasis on HIV clinical pharmacology.

Andrew Talal.

Beverly Joy Morrison

President and Chief Executive Officer, Mount Regale Practice Management

Beverly Joy Morrison has worked with nonprofit organizations for 40 years.  She worked with the Episcopal Diocese of Massachusetts at a local church level as well as serving on the Diocesan Council and the Bishop’s Executive Committee.  Her current nonprofit service is in the role of President of Jamaican and American Association of Buffalo and Recording Secretary for National Association of Jamaican and Supportive Organizations.  Morrison is a Board Member of Buffalo Jamaica Innovation Enterprise.  Beverly is President and CEO of a medical practice management company and is passionate in coordinating the care of patients.  She is a graduate of Boston College.  Above all, Beverly is the proud mother of Noelle and Vanessa; grandmother of Marc.

Andrew Talal.

William Pearce

Managing Partner, PEARCECO VENTURES, LLC

Previously President & CEO of Pearce & Pearce Co., Inc., a real estate management and investment firm. Prior to moving to Buffalo in 2000, was Senior Vice President and practice manager at Stern Stewart & Co., a corporate finance advisory firm based in New York City. Current and previous board service includes: 716 Squash (Treasurer); U.B. School of Social Work – Dean’s Advisory Council; Forest Lawn Heritage Foundation; Buffalo Jamaica Innovation Enterprise; Medaille College (Chairman, Advancement Committee; Executive Committee); Buffalo Seminary; Kaleida Health Foundation (Chairman); Buffalo Zoological Gardens capital campaign steering committee; Frank Lloyd Wright’s Fontana Boathouse;. Graduate of Lawrence University with a BA in Government.

Andrew Talal.

Trevor Poag, PhD

Director of Global Learning Opportunities, University at Buffalo

Trevor Poag is the Director of Global Learning Opportunities at the University of Buffalo.  Prior to that he served 11 years with the CCCU as Assistant Director and Faculty in the Latin American Studies program providing strategic leadership for field operations and learning initiatives at the study abroad center. HE completed his Doctor of Education, International Educational Leadership from Lehigh University.

Andrew Talal.

Satish Sharma, MD, FACS

Chairman and Chief Executive Officer, You First Services

Dr. Satish Sharma, MD, FACS is the Executive Chairman and Chief Executive Officer of You First Services Group of companies. He is also the Chairman of the Board of Directors of You First Services Group. Dr. Sharma is a clinical, technology and Innovation leader and provides leadership to various programs to enhance productivity, agility and affordability of company operations while expanding national and international operations. Dr. Sharma is also a Research Associate Professor with Department of Urology, Jacobs School of Medicine and Biomedical Sciences, the Clinical Director of Prostate cancer research program, Department of Medicine, Univeristy at Buffalo.

Andrew Talal.

Patrick Sheehan

Co-Founder and Executive Director, Peter Sheehan Diabetes Care Foundation

Son of the late Dr. Peter Sheehan, Patrick Sheehan is Executive Director of PSDCF, a foundation that unites research organizations, health systems, and industry companies to spur innovation that prevents diabetes and its complications, educate patients and professionals, and convene scientific leaders to advance research.

Andrew Talal.

Dorothy Siaw-Asamoah, PhD

Faculty Director of Global Programs, School of Management, University at Buffalo

Dr. Siaw-Asamoah is the UB School of Management's Founding Faculty Director of Global Programs, a newly-formed department that designs both in-person and virtual action learning projects for students to engage in both domestically and abroad. She also holds Board positions within the School of Managemnt Alumni Assocation's (SOMAA) Faculty Relations Committee and Hope for Sisi's Kids (HOSIKIDS) Foundation.

Andrew Talal.

Suzanne Siminski, MS, MBA

Chief Executive Officer, Frontier Science Foundation

Suzanne Siminski has been working in clinical trials data management and related research activities for more than 30 years. Sue has taken a leadership role in the development of Frontier Science’s laboratory data expertise and software. While Director of the New York office, Sue oversaw leadership groups involved in data management, software development, regulatory oversight and key projects. She currently serves as the Frontier Science Principal Investigator for PHACS and CPQA projects, and as co-Principal Investigator of the coordinating center for the C3PNO project, all programs funded by the NIH. As Chief Executive Officer of Frontier Science Foundation, Sue is strategically increasing the repertoire of clinical research services provided by the organization, and actively building global collaborative partnerships with investigators around the world. Sue’s entire CV is available here.

Andrew Talal.

Paul Tesluk, PhD

Dean and Professor, School of Management, University at Buffalo

Chair, Sustainable Leadership Development Committee

Paul Tesluk was named dean of the University at Buffalo School of Management in April 2016. A faculty member since 2011, Tesluk served as chair of the school’s Organization and Human Resources Department. He also founded and served as academic director of the Center for Leadership and Organizational Effectiveness, a university-supported applied research center with a mission to advance both research and practice related to leadership development and organizational effectiveness.